Key facts
- This page summarizes Matthew B. Klein's Form 4 filing for PTC THERAPEUTICS, INC. (PTCT).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 10 Jan 2025, 17:20.
Matthew B. Klein - 07 Jan 2025 Form 4 Insider Report for PTC THERAPEUTICS, INC. (PTCT)
- Reporting relationship
- CHIEF EXECUTIVE OFFICER, Director
- Issuer ticker
- PTCT
- Reported as of
- 07 Jan 2025
- Net transaction value
- -$204,007
- SEC form
- 4
- Accepted by SEC
- 10 Jan 2025, 17:20:11 UTC
- Prior SEC filing
- 07 Jan 2025
- Next SEC filing
- 21 Feb 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Avraham S. Adler, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Matthew B. Klein filed Form 4 for PTC THERAPEUTICS, INC. (PTCT) on 10 Jan 2025.
Change
- Previous filing in this sequence was filed on 07 Jan 2025.
- Current net transaction value: -$204,007.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PTCT
transaction
Common Stock
Sale
- Transaction value
- $97,118
- Shares
- -2,142
- Change %
- -0.74%
- Price
- $45.34
- Shares after
- 286,232
- Date
- 07 Jan 2025
- Ownership
- Direct
- Footnotes
- F1
PTCT
transaction
Common Stock
Sale
- Transaction value
- $106,889
- Shares
- -2,402
- Change %
- -0.84%
- Price
- $44.50
- Shares after
- 283,830
- Date
- 08 Jan 2025
- Ownership
- Direct
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Explanation of responses 2 footnotes
Footnote F1
Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 6,500 RSUs from a January 5, 2023 grant of 26,000 RSUs.
Footnote F2
Represents shares automatically sold pursuant to irrevocable sell to cover elections entered into upon acceptance of the respective grants to satisfy tax withholding obligations in connection with the vesting of 2,250 RSUs from a January 6, 2021 grant of 9,000 RSUs and the vesting of 15,250 RSUs from January 7, 2022 grants totaling 41,000 RSUs.